We provide you with 20 years of free, institutional-grade data for WVE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of WVE. Explore the full financial landscape of WVE stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-30 | 1631574 | WVE | 10-Q | Url |
| 2025-05-08 | 1631574 | WVE | 10-Q | Url |
| 2025-03-04 | 1631574 | WVE | 10-K | Url |
| 2024-11-12 | 1631574 | WVE | 10-Q | Url |
| 2024-08-08 | 1631574 | WVE | 10-Q | Url |
| 2024-05-10 | 1631574 | WVE | 10-Q | Url |
| 2024-03-06 | 1631574 | WVE | 10-K | Url |
| 2023-11-09 | 1631574 | WVE | 10-Q | Url |
| 2023-08-03 | 1631574 | WVE | 10-Q | Url |
| 2023-05-03 | 1631574 | WVE | 10-Q | Url |
| 2023-03-23 | 1631574 | WVE | 10-K | Url |
| 2022-11-10 | 1631574 | WVE | 10-Q | Url |
| 2022-08-11 | 1631574 | WVE | 10-Q | Url |
| 2022-05-12 | 1631574 | WVE | 10-Q | Url |
| 2022-03-03 | 1631574 | WVE | 10-K | Url |
| 2021-11-10 | 1631574 | WVE | 10-Q | Url |
| 2021-08-05 | 1631574 | WVE | 10-Q | Url |
| 2021-05-13 | 1631574 | WVE | 10-Q | Url |
| 2021-03-04 | 1631574 | WVE | 10-K | Url |
| 2020-11-09 | 1631574 | WVE | 10-Q | Url |
| 2020-08-10 | 1631574 | WVE | 10-Q | Url |
| 2020-05-11 | 1631574 | WVE | 10-Q | Url |
| 2020-03-02 | 1631574 | WVE | 10-K | Url |
| 2019-11-05 | 1631574 | WVE | 10-Q | Url |
| 2019-08-06 | 1631574 | WVE | 10-Q | Url |
| 2019-05-10 | 1631574 | WVE | 10-Q | Url |
| 2019-03-01 | 1631574 | WVE | 10-K | Url |
| 2018-11-09 | 1631574 | WVE | 10-Q | Url |
| 2018-08-09 | 1631574 | WVE | 10-Q | Url |
| 2018-05-09 | 1631574 | WVE | 10-Q | Url |
| 2018-03-12 | 1631574 | WVE | 10-K | Url |
| 2017-11-09 | 1631574 | WVE | 10-Q | Url |
| 2017-08-09 | 1631574 | WVE | 10-Q | Url |
| 2017-05-10 | 1631574 | WVE | 10-Q | Url |
| 2017-03-16 | 1631574 | WVE | 10-K | Url |
| 2016-11-09 | 1631574 | WVE | 10-Q | Url |
| 2016-08-15 | 1631574 | WVE | 10-Q | Url |
| 2016-05-16 | 1631574 | WVE | 10-Q | Url |
| 2016-03-30 | 1631574 | WVE | 10-K | Url |
| 2015-12-17 | 1631574 | WVE | 10-Q | Url |
| 2015-10-09 | 1631574 | WVE | S-1 | Url |
Wave Life Sciences Ltd(NASDAQ:WVE) 
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of ...
Website: http://www.wavelifesciences.com
Founded: 2012
Full Time Employees: 301
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about WVE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.